Summit Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $31M | 1.4M | 21.90 |
| 2024-06-30 | $1.6M | 209k | 7.80 |
| 2024-03-31 | $112k | 27k | 4.14 |
| 2023-12-31 | $42k | 16k | 2.61 |
| 2023-03-31 | $71k | 41k | 1.75 |
| 2022-12-31 | $1.1M | 253k | 4.25 |
| 2022-06-30 | $113k | 112k | 1.01 |
| 2022-03-31 | $32k | 13k | 2.44 |
| 2021-12-31 | $192k | 71k | 2.70 |
| 2021-09-30 | $219k | 44k | 5.00 |
| 2021-06-30 | $512k | 68k | 7.50 |
| 2021-03-31 | $331k | 56k | 5.87 |
| 2020-12-31 | $76k | 16k | 4.70 |